Merck & Company Inc (MRK)vsSpok Holdings Inc (SPOK)
MRK
Merck & Company Inc
$143.93
-0.54%
HEALTHCARE · Cap: $355.10B
SPOK
Spok Holdings Inc
$10.65
+0.19%
HEALTHCARE · Cap: $224.03M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 48860% more annual revenue ($66.57B vs $135.97M). SPOK leads profitability with a 9.0% profit margin vs 4.8%. SPOK trades at a lower P/E of 18.8x. SPOK earns a higher WallStSmart Score of 41/100 (D).
MRK
Hold36
out of 100
Grade: F
SPOK
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-73.7%
Fair Value
$82.84
Current Price
$143.93
$61.09 premium
Intrinsic value data unavailable for SPOK.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Conservative balance sheet, low leverage
Reasonable price relative to book value
Areas to Watch
Trading at 8.5x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Smaller company, higher risk/reward
Weak financial health signals
Revenue declined 1.9%
Earnings declined 10.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : SPOK
The strongest argument for SPOK centers on Debt/Equity, Price/Book.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 116.1x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : SPOK
The primary concerns for SPOK are Market Cap, Piotroski F-Score, Revenue Growth.
Key Dynamics to Monitor
SPOK carries more volatility with a beta of 0.42 — expect wider price swings.
MRK is growing revenue faster at 5.1% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SPOK scores higher overall (41/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Spok Holdings Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Spok Holdings, Inc., through its subsidiary, Spok, Inc., provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company is headquartered in Springfield, Virginia.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?